Fabrication of MCG and DMCG
C. granii species have been sourced from the Freshwater Algae Tradition Assortment, after which cultivated in 1-l flasks with synthetic seawater enriched utilizing f/2-Si media (pH 8.3) and maintained at 23 °C beneath a 12-h gentle/12-h darkish cycle with an illuminance of two,000 lx. After accumulating, C. granii cells have been sieved by means of a 75-μm nylon mesh and washed with deionized water. The filtered cells have been uncovered to a 1-M HCl answer at a ratio of two mg ml−1 for 12 h. The acid-treated C. granii was then sieved, washed with deionized water and launched into the Fe3O4 NP suspension (3 mg ml−1) at a ratio of 1 mg ml−1. After 12 h of incubation at room temperature with light agitation, the combination underwent sieving and washing processes for purified MCG. The ready MCGs have been blended with a DOX/Tris-HCl answer (1 mg ml−1, pH 8.4) at a ratio of 0.5 mg ml−1 and gently shaken for 12 h for drug loading. Subsequently, dopamine was added to the answer at a ratio of two mg ml−1, and the combination was shaken for 4 h to facilitate the formation of a PDA coating on the floor of MCG, yielding DOX-loaded DMCGs.
Magnetic actuation and movement evaluation of DMCGs
There are two magnetic actuation programs on this research. The primary is a custom-built tri-axial Helmholtz coil system outfitted with a personalized coil-driving system for programmable RMFs to characterize the movement of DMCGs in distinct regimes (Supplementary Sections 3 and 4). The second is an nRSM setup designed in-house for versatile operation in a bigger workspace and versatile swarm management in vivo (Supplementary Part 8). The movement and swarming behaviour of DMCGs was noticed and recorded utilizing a digital camera (MER-503-36U3C, Daheng Imaging). ImageJ plug-in Trackmate was used to analyse the movement of DMCGs. The move velocity subject induced by DMCG movement was measured utilizing PIV (Supplementary Part 11).
Numerical simulation of fluid move and solute transport
Simulation research have been carried out utilizing COMSOL Multiphysics 6.1 (Supplementary Part 12). The fluid move generated by DMCG movement was modelled utilizing the laminar move mannequin (equations (25)–(27) in Supplementary Part 13). To account for the nanoporous construction of DMCG, the laminar move mannequin was coupled with a porous media mannequin (equations (28)–(31) in Supplementary Part 13). Drug launch and penetration induced by DMCG rotation have been simulated utilizing a convective diffusion mannequin (equations (32) and (33) in Supplementary Part 13) and its variant for porous media (equations (34) and (35) in Supplementary Part 13). The magnetic subject was modelled in response to equation (36) in Supplementary Part 13. The rotational movement of DMCG was applied utilizing the dynamic mesh methodology for rotating domains in COMSOL.
Drug launch experiment with DOX-loaded DMCG
Right here 5 ml of PBS (pH 7.4) was positioned in a glass beaker, maintained at 25 °C beneath ambient circumstances. DOX-loaded DMCGs (5 mg, DOX focus of 100 μg ml−1 in suspension) have been launched and gently dispersed to acquire a homogeneous suspension. For single-DMCG-induced launch, the coil-based magnetic actuation system (Supplementary Fig. 3) was used to generate RMFs (denoted as B1–B4), inducing 4 distinct movement modes of particular person DMCGs. For every movement mode, the actuation frequency was set to 0, 1, 3 or 5 Hz and an identical magnetic flux density was maintained. At designated time factors (5, 10, 15, 20, 25 and 30 min), DMCGs have been magnetically sedimented to the underside of the container and 200 μl of supernatant (4% of the whole launch quantity) was withdrawn beneath light-protected circumstances to attenuate DOX photodegradation. An equal quantity of recent PBS was instantly replenished to take care of a relentless launch quantity and approximate near-sink circumstances. All experiments have been carried out with n = 3 impartial samples. Absorbance of the collected supernatant samples was measured at 488 nm utilizing a multifunctional microplate reader (SPARK, Tecan). For DMCG-swarm-induced launch, experiments have been performed beneath an identical DMCG mass, loading focus, buffer quantity and environmental circumstances utilizing the RMS (Supplementary Figs. 36 and 37). The swarms have been actuated within the locomotion (1 Hz) and swirling (5 Hz) regimes comparable to the movement classifications outlined above. Supernatant aliquots have been collected at 1, 5, 10, 20 and 30 min following the identical sampling and calculation protocol described for the single-body assays.
Preparation of hydrogel matrix and tumour spheroid
The hydrogel matrix and tumour spheroid are supposed as two bodily mimics of bladder tumour limitations. A 5% agarose answer was ready and microwaved for 1 min to make sure full dissolution. Subsequently, 2 ml of the answer was pipetted into every properly of a 12-well plate. Twelve cylindrical plastic moulds, every with a diameter of 1 mm, have been inverted and gently pressed into the agarose answer in every properly to a depth of 1 mm. The plates have been then allowed to face for 1 h to make sure full hydrogel solidification. As soon as solidified, the moulds have been eliminated to yield a hydrogel matrix containing microwells. The hydrogel was then immersed in an extra of PBS answer and weighed each 10 min to watch water uptake. Saturation was confirmed when the burden of the hydrogel stabilized, after which it was deemed prepared for the drug penetration experiments. If saturation was not achieved with one try, the hydrogel was reimmersed into PBS to repeat the earlier course of. For the preparation of tumour spheroids, every properly of a 96-well plate was crammed with a 1% agar answer. MTB-2 G3 cells (5,000–8,000 per properly) have been added, and after centrifugation at 300g for five min, the plate was incubated for roughly 4 days to advertise the formation of tumour spheroids.
In vitro evaluation of drug penetration in bladder-barrier mimic matrices
Convective drug penetration in hydrogel microwell: the hydrogel microwell was uncovered to an RMF (Bt3 = 10 mT, fr = 0 and three Hz; Supplementary Part 4), and was crammed with a 30-μl combination containing 0.1 mg ml−1 of MCG and 100 μg ml−1 of DOX. Particular fluorescence indicators of DOX have been then captured utilizing a fluorescence microscope, and pictures have been captured inside an interval of 30 s to evaluate DOX diffusion. Convective drug penetration in tumour spheroid: 3 ml of cell tradition medium containing a singular tumour spheroid was first added to a Petri dish, which was stored nonetheless for six h beneath cell tradition circumstances to facilitate adhesion of the tumour spheroid to the substrate. Subsequently, the tradition medium was eliminated and the Petri dish was uncovered to the identical magnetic subject used within the hydrogel microwell take a look at (Bt3 = 10 mT, fr = 0 and three Hz). Then, 1 ml of a mix containing MCG and DOX, with a mass-to-volume ratio of 0.2 mg ml−1 (100 μg ml−1), was launched into the Petri dish. The following statement of DOX diffusion in tumour spheroids adopted the protocol used within the above hydrogel experiments.
In vitro evaluation of drug supply in synthetic bladder tumour mannequin
The preparation of the hydrogel bladder tumour mannequin used a protocol much like that of the hydrogel microwell demonstrated above. Right here the cylindrical moulds have been changed with three-dimensional (3D) printed bladder tumour moulds. A 5% agarose answer was heated and poured right into a container that may embed the tumour moulds. Proper after pouring, the tumour moulds have been slowly inserted into the agarose answer, till they achieved good stability and full immersion. After full solidification of the hydrogel, the moulds have been gently eliminated to create a hydrogel cavity with a hump, which was supposed to imitate the bladder tumour. The as-prepared hydrogel was then immersed in an extra of PBS answer, and its weight was monitored periodically to make the hydrogel absorbance attain saturation earlier than getting used for subsequent experimental procedures. The DMCGs have been ready by mixing MCGs with an ICG answer (100 μg ml−1), utilizing a mass-to-volume ratio of 0.5 mg ml−1. Within the experimental group, 2 ml of the aforementioned suspension was launched into the hydrogel-mimicking bladder tumour mannequin. An RMS integrating our in-house everlasting magnet nRSM was utilized to collect the ICG-loaded MCG swarm on the urethral orifice of the unreal bladder, guiding them alongside the bladder wall to the simulated tumour area in a managed scrolling movement. The magnetic subject sample was then altered to induce swirling of the DMCG swarm within the tumour space, which was sustained for 40 min earlier than actively retrieving the DMCG swarm from the mannequin bladder utilizing the RMS. The complete course of was monitored and recorded beneath an in-house near-infrared area II imaging platform. Within the management group, 2 ml of ICG answer (100 μg ml−1) was added to the hydrogel bladder tumour mannequin, and the passive diffusion course of was documented over 40 min.
Ultrasound-guided DMCG actuation in folded/constrained bladder phantoms
Folded bladder-mimetic hydrogel phantoms have been fabricated utilizing 3D printed moulds containing predefined low-, medium- and high-rise fold in addition to rugae-mimetic undulating geometries and constricted passage buildings (minimal constriction, ~1 mm). Agarose hydrogel (4% w/v) containing silica microparticles (0.5% w/v, 10-μm diameter) was ready by first dispersing silica particles in deionized water beneath vigorous stirring to acquire a homogeneous suspension. Agarose powder was then added to the suspension, and the combination was heated to 95–100 °C with steady stirring till the whole dissolution of agarose was achieved. The ensuing particle-laden answer was poured into 3D printed moulds and allowed to chill to room temperature for gelation. DMCG swarms have been launched into the phantom lumen and visualized beneath real-time B-mode ultrasound imaging. The RMS was utilized to actuate and information the swarm throughout the folded geometries and narrow-neck constrictions beneath steady imaging steering. To evaluate move disturbances generated throughout actuation, Doppler ultrasound imaging was carried out at magnetic actuation frequencies of 1, 3 and 5 Hz. Localized Doppler sign depth inside folded and confined geometries was recorded to guage move technology beneath spatially restricted circumstances.
Housing circumstances of mice and rats and moral approval for animal experiments
Feminine C57BL/6 mice and feminine Sprague–Dawley (SD) rats have been housed in a specific-pathogen-free facility beneath a 12-h gentle/12-h darkish cycle, with managed ambient temperature (22 ± 2 °C) and relative humidity (50%–60%). Meals and water have been supplied advert libitum. All animal procedures described in subsequent sections have been authorised by the Animal Care and Use Committee of Xiamen College (accreditation numbers XMULAC20190065 and XMULAC20250009) and performed in accordance with institutional tips.
Ultrasound-guided DMCG navigation in mouse and rat bladders
Feminine C57BL/6 mice (6 weeks outdated) and feminine SD rats (12 weeks outdated) have been anaesthetized with isoflurane delivered through a fuel anaesthesia system and positioned supine on a high-frequency ultrasound imaging platform (Vevo 2100, VisualSonics), with limbs secured to attenuate movement artefacts. Following sterile preparation, a 24-G catheter was transurethrally inserted into the bladder lumen. A suspension of DMCGs in PBS (0.1 mg ml−1) was instilled intravesically (50 μl). Actual-time ultrasound imaging was used to visualise the bladder cavity and monitor the distribution of DMCGs. The RMS was utilized to actuate and management DMCGs alongside the urothelial floor beneath imaging steering. Rat experiments have been carried out utilizing the identical anaesthesia protocol, catheterization process, magnetic actuation parameters and ultrasound steering workflow as for mice, except in any other case specified.
In vivo analysis of drug diffusion in mouse and rat bladders
ICG-loaded DMCG (alternative of ICG moderately than DOX for in vivo fluorescence is detailed in Supplementary Part 24) was ready in response to the above-mentioned loading process by incubating 0.50 mg of MCG in 1.0 ml of ICG answer (200 μg ml−1), yielding a drug loading of twenty-two.8% (w/w). Unloaded free ICG within the suspension was eliminated by magnetic separation, and the product was lyophilized. For the in vivo administration of mouse bladders, mice have been randomly assigned to the passive diffusion group or the convective diffusion group (n = 3). Every mouse within the passive diffusion group acquired 50 μl of free-ICG answer (200 μg ml−1), comparable to an ICG dose of 10 μg per mouse. To make sure equal ICG dose between teams, every mouse within the convective diffusion group acquired 43.8 μg of DMCG dispersed in 50 μl of PBS. All samples have been instilled into the mouse bladder through the urethra. An RMF (3 Hz) was utilized over the bladder centre within the convective diffusion group utilizing the RMS system; no subject was utilized within the passive diffusion group. Fluorescence distribution within the bladder area was monitored utilizing an in vivo imaging system (Lumina III 2, PerkinElmer) at 0, 5, 10, 15, 20, 30, 40, 60, 100 and 120 min. Instantly after completion of the imaging process, the bladder tissues have been excised, opened longitudinally and completely rinsed with PBS to take away unbound ICG remaining within the bladder lumen, adopted by ex vivo fluorescence imaging of the collected tissues. For in vivo administration of SD rats (n = 3 per group), the anaesthesia, catheterization, dosing technique and magnetic actuation protocol have been an identical to these utilized in mice. In vivo fluorescence imaging was carried out at 0, 5, 10, 20 and 30 min. Instantly after imaging at 30 min, intravesical fluid or suspension was aspirated, and the bladder lumen was rinsed thrice with PBS to take away residual drug inside the cavity. In vivo fluorescence imaging was then repeated to evaluate retained and tissue-associated fluorescence indicators.
Development of mouse bladder tumour mannequin in vivo
Animals: feminine C57BL/6 mice, aged 6 weeks, have been sourced from the Xiamen College Animal Experiment Middle. Cells: MB49-LUC murine bladder most cancers cells, labelled with luciferase, have been utilized for the research. Mice have been anaesthetized utilizing 2% isoflurane at a move charge of 1.5 l min−1 with oxygen. As soon as totally anaesthetized, the mice have been positioned supine on a 37 °C heated pad. The decrease stomach was gently massaged to expel residual urine, adopted by depilation and disinfection of the urethral orifice with povidone–iodine answer. A 24-G intravenous catheter was inserted by means of the urethra into the bladder, and the bladder was flushed with 50 μl of PBS utilizing a 1-ml syringe, a course of repeated thrice. Subsequently, 50 μl of a PBS suspension containing 3 × 106 MB49-LUC cells was injected into the bladder. Anaesthesia was maintained for 1 h. Two days post-procedure, the institution of the tumour mannequin was confirmed utilizing small-animal fluorescence (Lumina III 2, PerkinElmer) and ultrasound imaging (Vevo2100, VisualSonics) programs. The utmost tumour dimension permitted by the institutional ethics committee was 10 × 10 × 10 mm3. Tumour dimension was monitored all through the research, and this restrict was not exceeded in any animal experiments.
In vivo analysis of drug penetration in mouse bladder tumour mannequin
Feminine C57BL/6 mice bearing bladder tumours have been randomly divided into convective diffusion and passive diffusion teams two weeks after tumour institution. Right here 50 μl free-DOX answer (800 μg ml−1, comparable to an intravesical therapeutic dose of roughly 2 mg kg−1 primarily based on mouse physique weight) was designated because the passive diffusion group, whereas DMCG containing an equal DOX dose (40 μg) was assigned to the convective diffusion group. DMCG was ready as described above by incubating 0.50 mg of MCG in 1.0 ml of DOX answer, yielding a drug loading of 27.95%. For in vivo administration, mice within the convective diffusion group (n = 4) acquired roughly 143 μg of DMCG dispersed in 50 μl of PBS, whereas mice within the passive diffusion group acquired the identical quantity of free-DOX answer. All formulations have been instilled into the mouse bladder through the urethra. Within the passive diffusion group, the catheter was sealed to retain the drug within the bladder for two h. The convective diffusion group underwent real-time ultrasound imaging steering, throughout which a swarm of DMCG particles was directed in direction of the tumour website utilizing the RMS beneath steering of ultrasound imaging. The RMS end-effector switched the magnetic subject mode to induce the swarm swirling beneath an RMF at 3 Hz for 30 min after which the DMCGs have been retained for 1.5 h to match the identical 2-h voiding cycle. After therapy, bladder contents from each teams have been aspirated utilizing a syringe and the bladder was rinsed thrice with PBS. Mice have been then euthanized, and bladders have been collected and glued. Frozen sections have been ready close to the biggest tumour floor and stained with DAPI. Fluorescence imaging of DAPI and DOX was carried out utilizing an Olympus VS200 automated slide scanning system, sustaining constant publicity settings throughout all samples.
Preclinical trial of intracavitary chemotherapy in mouse bladder tumour mannequin
Bladder tumour fashions have been established in mice as described beforehand. On day 6 post-tumour implantation (designated as day 0), tumour-bearing mice have been randomly divided into three teams: PBS, DOX and DMCG (n = 3 per group). On days 1, 3, 5 and seven, mice have been anaesthetized and intravesically instilled with the respective formulations, adopted by the corresponding procedures. The DOX and DMCG teams acquired remedies an identical to these of the passive diffusion and convective diffusion teams described within the aforementioned drug penetration assay within the bladder tumour mannequin, respectively. The PBS group acquired 50 μl of PBS per therapy, with different procedures per the DOX group. Mouse physique weight was monitored each day all through the therapy interval to guage systemic toxicity. Bioluminescence imaging of bladder tumours was carried out on days 0, 2, 4 and eight utilizing an IVIS Lumina III system (PerkinElmer). After the ultimate imaging on day 8, bladder tissues have been collected, mounted and sectioned for histological evaluation to additional consider the therapy efficacy. The tissue histology was assessed by haematoxylin and eosin staining, whereas tumour cell apoptosis and proliferation have been assessed by fluorescence co-staining with DAPI nucleus staining (blue), Ki-67 immunostaining (yellow) and TUNEL assay (inexperienced).
Statistics and reproducibility
Pattern dimension: no statistical strategies have been used to predetermine pattern sizes, however our pattern sizes are much like these reported in earlier publications57,58. The group dimension for every experiment is indicated within the corresponding determine legends or the Strategies.
Replication: all experiments have been independently repeated not less than thrice with related outcomes, except in any other case acknowledged within the determine legends. Organic and technical replicates have been distinguished the place applicable.
Knowledge exclusions: no animals or information factors have been excluded from the analyses, except explicitly famous.
Knowledge distribution: for parametric statistical analyses, information distribution was assumed to be regular, however this was not formally examined. To permit the direct evaluation of knowledge distribution, particular person information factors are proven the place relevant.
Randomization: animals have been randomly assigned to experimental and management teams earlier than therapy. Randomization was carried out manually with out devoted randomization software program. In vitro experiments didn’t contain allocation procedures requiring randomization.
Blinding: information assortment and evaluation weren’t carried out blind to the circumstances of the experiments. Potential bias was minimized through the use of prespecified, uniform acquisition and quantification settings, along with goal consequence metrics.
Statistical exams: all statistical exams have been carried out utilizing GraphPad Prism 9.4. Two-tailed Welch’s t-tests have been used for comparisons in Fig. 4j,n and Prolonged Knowledge Figs. 6b and 7b. Two-way repeated-measures evaluation of variance (ANOVA) with Šidák’s a number of comparisons take a look at was used for Fig. 6c,e. One-way ANOVA with Tukey’s a number of comparisons take a look at was used for Fig. 6h. Significance ranges are denoted as *P ≤ 0.05, **P ≤ 0.01 and ***P ≤ 0.001.
Reporting abstract
Additional info on analysis design is out there within the Nature Portfolio Reporting Abstract linked to this text.
